Real World Dialogues

A series dedicated to extinguishing the fear of cancer by inviting industry luminaries to discuss the latest research, their contributions to patient impact, and unlocking the potential of real-world data in transforming evidence to insights to improve access to high quality care.

Jump to:

The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations

April 7, 2021

During this webinar, we highlight strategic approaches you, and your organization, should consider as you invest in RWD to best capture the comprehensive patient journey needed to answer your most challenging questions, or seek to validate real-world endpoints. You will walk away having:

  • Built awareness on various RWD sources and their attributes, and how they are used to fill in the gaps to ensure your study design best reflects what is happening in the real-world
  • Taken the steps to understand whether artificial intelligence (AI) is a magical cure-all, or is it perpetuating inconsistencies or biases already in the data?
  • Learned how to take unstructured lab and pathology reports (including biomarker data) using NLP to ensure your study design best reflects what is happening in the real-world to generate more robust data

Real-World Dialogue: Leroy (Lee) Hood, MD, PhD

February 23, 2021

In this dialogue, Dr. Thomas Brown, chief medical officer at Syapse, hosts Dr. Leroy (Lee) Hood, co-founder of Institute for Systems Biology (ISB) and discusses genomic profiling, molecular biotechnology, and the future of research. A world-renowned scientist and recipient of the National Medal of Science in 2011, Dr. Leroy Hood co-founded the Institute for Systems Biology (ISB) in 2000 and served as its first President from 2000-2017.

Dr. Hood has played a role in founding 15 biotechnology companies including Amgen, Applied Biosystems, Arivale, and Nanostring. He has co-authored textbooks in biochemistry, immunology, molecular biology, genetics, and systems biology.


What's new

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

SAN FRANCISCO, NEW YORK, July 27, 2022 —Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $35 million growth funding transaction to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.



Unlocking the Value of Real-World Data to Provide Real-World Care

For this video interview, we spoke with Mary Tran, MS, from Syapse for a deep dive into the strengths, weaknesses, and challenges of real-world data (RWD). Mary also explains some effective multi-source RWD strategies to transform patient data into patient experience.